111 related articles for article (PubMed ID: 7520108)
1. Pulmonary toxicity of bleomycin: is G-CSF a risk factor?
Bastion Y; Coiffier B
Lancet; 1994 Aug; 344(8920):474. PubMed ID: 7520108
[No Abstract] [Full Text] [Related]
2. Possible toxicity with the association of G-CSF and bleomycin.
Bastion Y; Reyes F; Bosly A; Gisselbrecht C; Yver A; Gilles E; Maral J; Coiffier B
Lancet; 1994 May; 343(8907):1221-2. PubMed ID: 7513778
[No Abstract] [Full Text] [Related]
3. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
Saxman SB; Nichols CR; Einhorn LH
Chest; 1997 Mar; 111(3):657-60. PubMed ID: 9118704
[TBL] [Abstract][Full Text] [Related]
5. [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis].
Skurikhin EG; Andreeva TV; Khmelevskaia ES; Ermolaeva LA; Pershina OV; Ermakova NN; Stepanova IE; Reztsova AM; Krupin VA; Gol'dberg VE; Reĭkhart DV; Dygaĭ AM
Eksp Klin Farmakol; 2012; 75(1):30-3. PubMed ID: 22442961
[TBL] [Abstract][Full Text] [Related]
6. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
Lei KI; Leung WT; Johnson PJ
Br J Cancer; 1994 Nov; 70(5):1009-13. PubMed ID: 7524599
[TBL] [Abstract][Full Text] [Related]
7. The role of screening and monitoring for bleomycin pulmonary toxicity.
Shippee BM; Bates JS; Richards KL
J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary toxicity during granulocyte colony stimulating factor administration and neutrophils.
Katoh M; Takada M; Nakayama M; Umeda M
Chest; 1996 Aug; 110(2):576-7. PubMed ID: 8697875
[No Abstract] [Full Text] [Related]
9. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
Noël-Savina E; Descourt R
Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
[TBL] [Abstract][Full Text] [Related]
10. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
11. The effect of concomitant use of Colony-Stimulating factors on bleomycin pulmonary toxicity - A systematic review and meta-analysis.
Mahdi Seyedzadeh Sani S; Sahranavard M; Jannati Yazdanabad M; Seddigh Shamsi M; Elyasi S; Hooshang Mohammadpour A; Sathyapalan T; Arasteh O; Ghavami V; Sahebkar A
Int Immunopharmacol; 2022 Nov; 112():109227. PubMed ID: 36099787
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
Yokose N; Ogata K; Tamura H; An E; Nakamura K; Kamikubo K; Kudoh S; Dan K; Nomura T
Br J Cancer; 1998 Jun; 77(12):2286-90. PubMed ID: 9649147
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data.
Azoulay E; Attalah H; Harf A; Schlemmer B; Delclaux C
Chest; 2001 Nov; 120(5):1695-701. PubMed ID: 11713155
[No Abstract] [Full Text] [Related]
15. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
Ho P; Sherman P; Grigg A
Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
[TBL] [Abstract][Full Text] [Related]
16. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
Bennett WM; Pastore L; Houghton DC
Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Martin WG; Ristow KM; Habermann TM; Colgan JP; Witzig TE; Ansell SM
J Clin Oncol; 2005 Oct; 23(30):7614-20. PubMed ID: 16186594
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
Cooper KR; Hong WK
Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
[TBL] [Abstract][Full Text] [Related]
19. Effects of granulocyte colony-stimulating factor on the kinetics of inflammatory cells in the peripheral blood and pulmonary lesions during the development of bleomycin-induced lung injury in rats.
Adachi K; Suzuki M; Sugimoto T; Uetsuka K; Nakamaya H; Doi K
Exp Toxicol Pathol; 2003 Jul; 55(1):21-32. PubMed ID: 12940625
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]